Vetter Newsroom
Maximizing the value of a compound in clinical development
Paul Nelles, Ph.D., Vice President of Vetter Development Services offers his thoughts on how a CDMO can help you . More...
Aseptic filling of biotechnology drugs at Vetter in Skokie
Learn how Vetter’s efforts can help achieve the highest level of aseptic filling in the May 28 edition of the Skokie Review. More...
Webinar "Navigating the Future of Aseptic Manufacturing" is now available
This webinar outlines and demonstrates how outsourcing your aseptic filling can achieve benefits. More...
A new way of looking at manufacturing and delivery
Changes in the industry will require strategic partnerships in the prefilled syringe segment that respond to the numerous challenges. More...
What exactly is Manufacturing Excellence and how do you achieve it in your facility?
Manufacturing excellence is more than a phrase loosely applied to today’s sterile pre-filled syringe manufacturing facilities. More...
Vetter Pharma creates a “Buzz” at the BIO International Convention in Chicago
Dr. Claudia Roth, President, Vetter Development Services, USA provides insight into the company’s first site outside of Germany. More...
Vetter Answers
Lyophilization
More and more of today’s (and tomorrow’s) drugs are biotech drugs, complex and often highly sensitive molecules. External factors such as oxygen, sunlight, and pH values can negatively affect biotech products, leaving marketers looking for innovative ways to protect and preserve these important compounds until they can be administered.
